← SynDRA
SYN1604603
SynDRA canonical compound SYN1604603 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GABBR1 |
|---|
| Mechanism of action | GABA receptor positive allosteric modulator |
|---|
All known targets
- GABBR1
- GABBR2
- KCTD12
- KCTD16
- KCTD8
Mechanisms of action (all sources)
- GABBR1 POSITIVE ALLOSTERIC MODULATOR
- GABBR2 POSITIVE ALLOSTERIC MODULATOR
- KCTD8 POSITIVE ALLOSTERIC MODULATOR
- KCTD12 POSITIVE ALLOSTERIC MODULATOR
- KCTD16 POSITIVE ALLOSTERIC MODULATOR
Cross-references
Synonyms
- (+)-BHFF
- FN0
- GTPL5504
- SCHEMBL2371847
- RVNOANDLZIIFHB-INIZCTEOSA-N
- racBHFF
- rac BHFF?
- AKOS022017970
- RefChem:528162
- HY-103519
- BHFF
- MFCD03764148
- rac BHFF, >=98% (HPLC)
- rac-BHFF
- GTPL10267
- SCHEMBL30618192
- SCHEMBL2371840
- EU-0053641
- NCGC00370908-10
- AKOS001738667
- CS-0028020
- NCGC00370908-01
- AC-38099
- T4176
- DA-77320
- F861597
- K3W3822BMV
- orb1303088
- AS-80062
- BDBM50427614
- CCG-222445
- N17055
- UNII-K3W3822BMV
Look up SYN1604603 in the interactive SynDRA portal →